New study identifies gene implicated in Alzheimers disease
Alzheimers disease is a devastating and progressive neurodegenerative disorder characterized by rapidly declining memory motor skills personality speech and personality-related cognitive difficulties. Novel gene mutations that modulate simple metabolism throughout the body may result in a novel therapeutic target for Alzheimers disease.
A large-scale genetic study by Maryland researchers identified and mapped gene transcription signatures activated during hippocampal-induced hypometabolism (HILM) in mice. The findings being published in Cell Reports suggest the involvement of the brains mitochondrial gene MITF in Alzheimers disease and highlight MITF as a potential patient therapeutic target.
Researchers at the Johns Hopkins University School of Medicine have developed a new online tool to help clinicians monitor or avoid preventable harm from a patients inherent risk for certain diseases such as pain rheumatoid arthritis recurrent sinus infections or viral or bacterial pneumonia. 
Customized cancer therapy for skin cancer patients has gained control as the cells no longer seem to make up the tumour but rather disappear in a complete photo-compatible fashion. Here is how. 
India will sign an agreement with private companies to manufacture two of the five biologic drugs required by the U. S. Food and Drug Administration to be approved by July 1 a senior government official said as a flood of low-income drug options in the country wiped out a captive market. 
Stimulating T-cells with a new antibody that destroyed a subtype of solid ovarian cancer or polycystic ovarian hormone receptor-negative type 2 (OC-HR-N2) boosted tumor protection in an animal model. The antibody was co-developed by a research team led by Kunming Ren and Qun Bill Yingyi from the department of international affairs and health. The research team aimed to improve the potential of cancer immunotherapy by bypassing the need to use antibodies which do not work against cancer cells yet. 
Scientists at Trinity College Dublin have begun a late-stage trial testing a drug to treat asthma having been unsuccessful in producing definitive results. 
Weight-control interventions can prove to be a lifesaver helping to extend peoples lives and lowering their risk of cardiovascular diseases a new study has shown.